TD Asset Management »

Halozyme Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2012-12-31 $105k 16k 6.73
2012-09-30 $118k 16k 7.56
2012-06-30 $138k 16k 8.85
2012-03-31 $172k 14k 12.74
2011-12-31 $146k 15k 9.54
2011-09-30 $94k 15k 6.14
2011-06-30 $106k 15k 6.93
2011-03-31 $103k 15k 6.73
2010-12-31 $121k 15k 7.91